» Articles » PMID: 16963550

Use of Native Lactococci As Vehicles for Delivery of DNA into Mammalian Epithelial Cells

Overview
Date 2006 Sep 12
PMID 16963550
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

The use of the food-grade bacterium Lactococcus lactis as a DNA delivery vehicle at the mucosal level is an attractive DNA vaccination strategy. Previous experiments showed that recombinant L. lactis expressing the Listeria monocytogenes inlA gene can deliver a functional gene into mammalian cells. Here, we explored the potential use of noninvasive L. lactis strains as a DNA delivery vehicle. We constructed two Escherichia coli-L. lactis shuttle plasmids, pLIG:BLG1 and pLIG:BLG2, containing a eukaryotic expression cassette with the cDNA of bovine beta-lactoglobulin (BLG). The greatest BLG expression after transfection of Cos-7 cells was obtained with pLIG:BLG1, which was then used to transform L. lactis MG1363. The resulting L. lactis strain MG1363(pLIG:BLG1) was not able to express BLG. The potential of L. lactis as a DNA delivery vehicle was analyzed by detection of BLG in Caco-2 human colon carcinoma cells after 3 h of coincubation with (i) purified pLIG:BLG1, (ii) MG1363(pLIG:BLG1), (iii) a mix of MG1363(pLIG) and purified pLIG:BLG1, and (iv) MG1363. Both BLG cDNA and BLG expression were detected only in Caco-2 cells coincubated with MG1363(pLIG:BLG1). There was a decrease in the BLG cDNA level in Caco-2 cells between 24 and 48 h after coincubation. BLG expression by Caco-2 cells started at 24 h and increased between 24 and 72 h. BLG secretion by Caco-2 cells started 48 h after coincubation with MG1363(pLIG:BLG1). We conclude that lactococci can deliver BLG cDNA into mammalian epithelial cells, demonstrating their potential to deliver in vivo a DNA vaccine.

Citing Articles

Lactococcus lactis engineered to deliver hCAP18 cDNA alleviates DNBS-induced colitis in C57BL/6 mice by promoting IL17A and IL10 cytokine expression.

Nogues E, Kropp C, Betemps L, de Sousa C, Chain F, Auger S Sci Rep. 2022; 12(1):15641.

PMID: 36123355 PMC: 9485145. DOI: 10.1038/s41598-022-19455-3.


Vaccination against Bacterial Infections: Challenges, Progress, and New Approaches with a Focus on Intracellular Bacteria.

Osterloh A Vaccines (Basel). 2022; 10(5).

PMID: 35632507 PMC: 9144739. DOI: 10.3390/vaccines10050751.


Prospecting of potentially probiotic lactic acid bacteria from bovine mammary ecosystem: imminent partners from bacteriotherapy against bovine mastitis.

Steinberg R, Silva E Silva L, de Souza M, Reis R, Bicalho A, Nunes J Int Microbiol. 2021; 25(1):189-206.

PMID: 34498226 DOI: 10.1007/s10123-021-00209-6.


Novel Strategies for Efficient Production and Delivery of Live Biotherapeutics and Biotechnological Uses of : The Lactic Acid Bacterium Model.

Tavares L, de Jesus L, da Silva T, Barroso F, Batista V, Coelho-Rocha N Front Bioeng Biotechnol. 2020; 8:517166.

PMID: 33251190 PMC: 7672206. DOI: 10.3389/fbioe.2020.517166.


Mucosal delivery of Lactococcus lactis carrying an anti-TNF scFv expression vector ameliorates experimental colitis in mice.

Chiabai M, Almeida J, de Azevedo M, Fernandes S, Pereira V, de Castro R BMC Biotechnol. 2019; 19(1):38.

PMID: 31238939 PMC: 6593574. DOI: 10.1186/s12896-019-0518-6.


References
1.
Bermudez-Humaran L, Langella P, Cortes-Perez N, Gruss A, Tamez-Guerra R, Oliveira S . Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production. Infect Immun. 2003; 71(4):1887-96. PMC: 152106. DOI: 10.1128/IAI.71.4.1887-1896.2003. View

2.
Schaffner W . Direct transfer of cloned genes from bacteria to mammalian cells. Proc Natl Acad Sci U S A. 1980; 77(4):2163-7. PMC: 348672. DOI: 10.1073/pnas.77.4.2163. View

3.
Houde M, Bertholet S, Gagnon E, Brunet S, Goyette G, Laplante A . Phagosomes are competent organelles for antigen cross-presentation. Nature. 2003; 425(6956):402-6. DOI: 10.1038/nature01912. View

4.
Mannam P, Jones K, Geller B . Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes. Infect Immun. 2004; 72(6):3444-50. PMC: 415684. DOI: 10.1128/IAI.72.6.3444-3450.2004. View

5.
Papiz M, Sawyer L, Eliopoulos E, North A, Findlay J, Sivaprasadarao R . The structure of beta-lactoglobulin and its similarity to plasma retinol-binding protein. Nature. 1986; 324(6095):383-5. DOI: 10.1038/324383a0. View